![美股盘前:阿斯麦涨近2% 台积电斥资123亿美元“扫货”,ASML光刻机出货量将增长30%](https://i-invdn-com.investing.com/news/LYNXMPEA7H0NX_S.jpg)
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
aTyr Pharma Inc 是一家生物治疗公司,致力于发现和开发基于新型生物途径的药物。其治疗候选药物包括efzofitimod(ATYR1923)、ATYR2810、NRP2 mAb、AARS-1 和DARS-1。ATYR1923是一种融合蛋白,由与人抗体的可结晶片段(Fc)区域融合的组氨酰-tRNA合成酶的免疫调节结构域组成,可作为NRP2的选择性调节剂,在炎症状态下下调先天性和适应性免疫反应。该公司还在开发efzofitimod,作为一种潜在的疾病改善疗法,用于治疗具有高度未满足医疗需求的纤维化肺病患者。ATYR2810是一种完全人源化的单克隆抗体,可特异性地在功能上阻断NRP2与其一个主要配体VEGF之间的相互作用。ATYR2810正处于临床前开发阶段,用于潜在治疗涉及NRP2的某些侵袭性癌症。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Osamu Nureki | - | 2009 | Member of Scientific Advisory Board |
Wing Hung Wong | - | - | Member of Scientific Advisory Board |
John K. Clarke | 70 | 2005 | Independent Director |
Nancy Ip | - | - | Member of Scientific Advisory Board |
Timothy J. Rink | 78 | 2011 | Member of Therapeutic Advisory Board |
Paul Negulescu | - | 2011 | Member of Therapeutic Advisory Board |
R. Alan B. Ezekowitz | 70 | - | Member of Therapeutic Advisory Board |
Sanjay S. Shukla | 52 | 2016 | President, CEO & Director |
Svetlana Lucas | 52 | 2019 | Independent Director |
Sara L. Zaknoen | 65 | 2021 | Independent Director |
Paul R. Schimmel | 83 | 2005 | Independent Director |
Benjamin F. Cravatt | 53 | - | Member of Scientific Advisory Board |
Douglas Edward Williams | 66 | 2011 | Member of Therapeutic Advisory Board |
Bruce A. Beutler | - | 2009 | Member of Scientific Advisory Board |
Leonard Patrick Gage | 82 | 2011 | Member of Therapeutic Advisory Board |
Keith James | - | 2011 | Member of Therapeutic Advisory Board |
Arthur M. Mercurio | - | 2020 | Scientific Advisor |
Timothy P. Coughlin | 57 | 2017 | Independent Chairman of the Board |
Jane A. Gross | 67 | 2019 | Independent Director |
Thomas O. Daniel | 70 | 2011 | Member of Therapeutic Advisory Board |
Wendell D. Wierenga | 76 | 2011 | Member of Therapeutic Advisory Board |
Floyd E. Bloom | 87 | 2009 | Member of Scientific Advisory Board |
Susan L. Ackerman | - | - | Member of Scientific Advisory Board |
Richard A. Heyman | 67 | 2011 | Member of Therapeutic Advisory Board |
Judith Varner | - | 2021 | Scientific Advisor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核